In the third year of the new crown, the global anti-epidemic form has improved, and the medical tourism exhibition has helped the industry recover
2022-02-21
In 2022, the COVID-19 pandemic will enter its third year. With the general increase in global vaccination rates, many countries have begun to gradually relax travel restrictions. Due to the relatively successful control of the domestic epidemic and the huge consumer market, Chinese tourists have become a favorite, and countries around the world have introduced quarantine-free policies for Chinese inbound tourists. In the future, the general environment will get better and better. Cross-border medical care has gradually recovered from suffocation and freezing point to the gradual recovery of the market, which has given hope to many practitioners.
01The third year of the new crown, listen to experts' views on the epidemic
WHO Director-General Tedros Adhanom Ghebreyesus expressed his optimism that "in 2022 we will not only end the acute phase of the pandemic, but also open a path to enhanced health security." Immunity is one way to end an outbreak. Some experts also believe that people need to change their minds and accept the fact that it has become a common epidemic like a cold; Dr. Bonnie Henry, the health officer of British Columbia, believes in a year-end interview that the new crown has the potential to end the pandemic in the spring of 2022 and become a local epidemic. sexually transmitted diseases. Zhang Wenhong, a Chinese expert, said on December 17 that this winter and the Spring Festival, we will spend the last cold winter with the international community, and we will eventually "pull out the clouds to see the sun, and keep the clouds open to see the moon," Zhong Nanshan said. It is believed that with the launch of new crown specific drugs and the herd immunity target of 82% vaccination by the end of the year, they are optimistic about epidemic prevention and control.
02Major changes in the macro environment at home and abroad
1. In terms of international policy, the RCEP "Regional Comprehensive Economic Partnership Agreement" will take effect from January 1, 2022
This means that in-depth cooperation between regional countries has been fully upgraded. RCEP is the world's largest free trade agreement. At present, six ASEAN countries and China, Japan, New Zealand, and Australia have officially submitted their approval documents, and it will take effect on January 1, 2022. For ordinary people, it means more favorable prices, better services, employment in various countries in the region, and visa convenience for eligible people.
It is believed that this agreement will also make cross-border medical tourism at home and abroad more convenient and beneficial. In addition, the deepening of multi-country cooperation between regions also means that the destination countries of medical tourism have also changed. Frankly speaking, countries with better diplomatic relations with China will inevitably gain some expansion of the Chinese consumer market in the future. However, for international patients, the medical level and medical resources of the destination country are also the core influencing factors. After all, the purpose of cross-border medical treatment for patients is to solve their health concerns.
2. Market opportunities for medical tourism subdivision projects, policies and markets are favorable for the development of the industry
Assisted reproduction: In 2021, the official opening of the three-child policy and the huge infertility population will be the biggest driving force for the assisted reproduction market. Recently, Zeping macro published an article pointing out that don't expect the post-90s and post-00s to have children, but to seize the stage of 75 to 85 years, which means that it is necessary to strengthen the encouragement of families to have "second children" and "third children". "When couples miss the optimal reproductive age and the probability of natural successful conception is low, assisted reproductive technology ushered in a broad application space at this time. In addition, local governments are currently introducing a series of subsidies or support policies to support the birth of babies, and it is expected to see practical results in 2-3 years. On the other hand, there are about 50 million infertile groups in China, and by 2020, there are only 536 medical institutions approved to carry out human assisted reproductive technology in my country. Obviously, the assisted reproduction market is already in short supply, and the huge demand group will promote Expansion of the assisted reproductive market at home and abroad.
Early tumor screening and cancer treatment: In 2020, there will be 4.57 million new cancer cases in my country, accounting for 23.7% of the world's total, and an average of 8 people will be diagnosed every minute. Malignant tumors have become a major public health problem threatening the health of the Chinese population. The "three early principles" (ie, early detection, early diagnosis and early treatment) of cancer are the most effective methods to reduce cancer mortality.
Behind the early screening of tumors is the intensification of tumor rejuvenation and the deep aging of the population. It is predicted that by 2040, the number of elderly people aged 60 and above in China will reach 483 million! Deep aging will further deepen the incidence of cancer. According to the definition of the guidelines of the Chinese Society of Clinical Oncology, it is estimated that in 2023, there will be about 120 million high-risk people for liver cancer, 95.8 million high-risk people for lung cancer, and 246 million high-risk people for gastric cancer in China. Early cancer screening is aimed at a large number of potential crowd.
In terms of cancer treatment, overseas, especially developed countries such as Europe and the United States, attract many cancer patients to seek medical treatment overseas due to factors such as advanced medication and medical technology.
At this stage, with the gradual opening of borders and the gradual recovery of international flows, some international hospitals have opened to international patients in an orderly manner. In order to better prepare for the recovery and warm-up of the cross-border medical tourism market, the 17th Beijing International Medical Tourism Exhibition will be held at the China International Exhibition Center (Jing'an Zhuang Pavilion) from July 8 to 10. We hope to invite More industry practitioners have joined this big family to seize the new opportunities and new trends of medical tourism in the post-epidemic era.
Combined with favorable factors such as the increase in vaccine coverage, the availability of specific drugs, and people's rich experience in anti-epidemic and epidemic prevention, the impact of the epidemic is the darkness before dawn.
The 17th Beijing International Medical Tourism Exhibition will be held at China International Exhibition Center on July 8010. Zhenghe Exhibition hopes that this exhibition can integrate relevant industrial resources, help to expand and consolidate channel cooperation with international hospitals and medical service institutions, and share New opportunities to promote the recovery and development of the industry.
At present, the exhibition's investment promotion is in full swing, and colleagues in the industry are welcome to actively consult and participate!
